Your browser doesn't support javascript.
loading
How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview.
Empeslidis, Theodoros; Storey, Matthew; Giannopoulos, Theodoros; Konidaris, Vassileios; Tranos, Paris G; Panagiotou, Evangelia S; Voudouragkaki, Irini C; Konstas, Anastasios G.
Afiliação
  • Empeslidis T; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK.
  • Storey M; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK.
  • Giannopoulos T; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Konidaris V; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK.
  • Tranos PG; Ophthalmica Eye Institute, Thessaloniki, Greece.
  • Panagiotou ES; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Voudouragkaki IC; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Konstas AG; 1st and 3rd University Departments of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece. konstas@med.auth.gr.
Adv Ther ; 36(7): 1532-1548, 2019 07.
Article em En | MEDLINE | ID: mdl-31102206

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Substituição de Medicamentos / Bevacizumab / Ranibizumab / Degeneração Macular Tipo de estudo: Guideline / Overview / Prognostic_studies / Systematic_reviews Limite: Aged / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Substituição de Medicamentos / Bevacizumab / Ranibizumab / Degeneração Macular Tipo de estudo: Guideline / Overview / Prognostic_studies / Systematic_reviews Limite: Aged / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article